Incidence and Estimated Vaccine Effectiveness Against Hospitalizations for All-Cause Pneumonia Among Older US Adults Who Were Vaccinated and Not Vaccinated With 13-Valent Pneumococcal Conjugate Vaccine

IMPORTANCE: Following routine use of 13-valent pneumococcal conjugate vaccine (PCV13) in children in 2010, invasive pneumococcal disease rates have decreased substantially in children and adults. In 2014, the Advisory Committee for Immunization Practices recommended routine use of PCV13 among adults...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsiao, Amber, Hansen, John, Timbol, Julius, Lewis, Ned, Isturiz, Raul, Alexander-Parrish, Ronika, McLaughlin, John M., Gessner, Bradford D., Klein, Nicola P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933738/
https://www.ncbi.nlm.nih.gov/pubmed/35302634
http://dx.doi.org/10.1001/jamanetworkopen.2022.1111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933738/
https://www.ncbi.nlm.nih.gov/pubmed/35302634
http://dx.doi.org/10.1001/jamanetworkopen.2022.1111

Ejemplares similares